Mice were dark adapted overnight. Mice were anesthetized using a ketamine/xylazine mixture (87.5 mg/kg ketamine, 12.5 mg/kg xylazine), and 1% tropicamide ophthalmic solution was applied for 3 min prior to the ERG procedure.
GONAK hypromellose ophthalmic demulcent solution (NDC 17478-064, Akorn) was applied on the eyes prior to electrode placement. ERG was performed using the
Celeris system from Diagnosys (Lowell, MA). To assess rod function, mice were subjected to dim flashes of 0.01 cd s/m
2 under dark-adapted conditions. Combined rod-cone function was measured by bright flashes of 3.0 cd s/m
2 under dark-adapted conditions. To assess cone function, mice were light adapted for 10 min to bleach rods in the retina. Then, two different measures, one involving isolated 3.0 cd s/m
2 bright flashes and the other using a train of 5-Hz flickering light, were used to evaluate the functions of cones. These tests are standardized ERG testing protocols established by the ISCEV.
42 (
link) Statistical analysis of ERG amplitudes was performed with GraphPad
PRISM 9.0 using two-way ANOVA. Values shown are averages ± standard error of the mean.
Hsu Y., Bhattarai S., Thompson J.M., Mahoney A., Thomas J., Mayer S.K., Datta P., Garrison J., Searby C.C., Vandenberghe L.H., Seo S., Sheffield V.C, & Drack A.V. (2022). Subretinal gene therapy delays vision loss in a Bardet-Biedl Syndrome type 10 mouse model. Molecular Therapy. Nucleic Acids, 31, 164-181.